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We are pleased to present this special supplement of
Current Oncology, which is generously financed by a
grant from the Lotte and John Hecht Memorial Foun-
dation. Integrative oncology is both a science and a
philosophy that focuses on the complexity of the health
of cancer patients and proposes a multitude of ap-
proaches to accompany the conventional therapies of
surgery, chemotherapy, molecular therapeutics, and
radiotherapy to facilitate health. As such, integrative on-
cology involves thinking outside the box, and so we are
indeed fortunate to have attracted a plethora of manu-
scripts from innovative leaders both of Canadian and of
international cancer treatment and control services.
In line with the modern approach to media com-
munications, we have “integrated” this issue with
manuscripts published on the Current Oncology Web
site. Readers will also have the opportunity to view
and listen to slide presentations submitted to the Inte-
grating Wellness into Cancer Care Conference held at
the University of Toronto, October 4–5, 2007. The con-
ference was organized by Dr. Paul Fortin in memory
of his wife Dr. Veronique Benk. Veronique was a ra-
diation oncologist, clinician, and researcher who spe-
cialized in breast cancer, and she was devoted to her
patients. Her personal experience of breast cancer and
myeloid leukemia was transformative, and she em-
braced a wider approach to cancer treatment. That
approach prioritized state-of-the-art medical care with
a new emphasis on spirituality, wellness, and quality
of life. The conference was sponsored by a non-re-
stricted educational grant from the Lotte and John
Hecht Memorial Foundation, CV Technologies, Astra/
Zeneca Pharmaceuticals, Pfizer Pharmaceuticals,
Novartis Pharmaceuticals, Wellspring, and the Uni-
versity of Toronto Department of Radiation Oncol-
ogy, with special thanks to Drs. Mary Gospodarowicz
and Pamela Catton.
PURSUING THE INTEGRATIVE PATH
So, what is CAM?
Complementary and alternative medicine (CAM) is
an umbrella term encompassing a group of diverse medi-
cal and health care systems, practices, and products that
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are not always considered part of conventional medi-
cine 1. Yet in traditional healing systems, the power of
the mind and other non-pharmaceutical interventions
are integral to the treatment of ill health.
Promotion, maintenance, monitoring, or restora-
tion of health is the goal of CAM use. According to the
U.S. National Cancer Institute, CAM includes whole
medical systems (for example, Traditional Chinese
Medicine), mind–body medicine (meditation, for in-
stance), biologically-based practices (natural health
products, among others), manipulative and body-based
therapies (for example, massage), and energy thera-
pies (qi gong, for instance) 1.
An approach is called “complementary” when it
is used adjunctively to conventional treatments, with
the intent to enhance the body’s natural abilities to heal.
Modalities used instead of conventional treatments are
labelled “alternative” therapies. The term “alternative”
means that treatments outside of conventional medi-
cine are used to treat the disease. Depending on intent,
some therapies can be considered either complemen-
tary or alternative. It is therefore important always to
clarify the intent of the patient considering CAM use.
Studies have consistently found that most cancer
patients use CAM as a complement to their conven-
tional treatment 2,3.
The lack of consensus around terminology and defi-
nitions makes it difficult to accurately assess the preva-
lence of CAM use. For example, the list of products
and therapies designated as CAM continually changes
as therapies that are proved to be safe and effective
are integrated into conventional health care and as new,
untested ones emerge 4.
An increasing number of people living with can-
cer are using therapies in addition to those prescribed
by conventional health care providers 5,6. In the litera-
ture, an explosion of CAM surveys has suggested that
utilization rates by cancer patients fall between 40%
and 60% 7. For example, with the inclusion of prayer
in the CAM list, the prevalence of CAM use in the
United States is estimated at 62%; minus prayer, it is
about 36% 8.
Integrative oncology does not usually incorporate
prayer into its definition of therapies, preferring to classifyINTEGRATIVE ONCOLOGY: A CANADIAN AND INTERNATIONAL PERSPECTIVE
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prayer in a religious domain, but the concept of prayer
as a mind–body intervention illustrates the challenge
of defining a CAM therapy 9. Throughout the cancer
trajectory, higher use of CAM is consistently found dur-
ing chemotherapy to mitigate adverse effects, after
conventional cancer treatment to boost energy, during
survivorship to foster wellness, and during the last
months of life to control symptoms 10.
For this special issue, the term “CAM” is being
used because of its worldwide recognizability as a la-
bel linked to traditional medicine. Given the specific
focus of this issue on integrative medicine, CAM
uniquely refers to the complementary side—in other
words, to something used in conjunction with conven-
tional oncology treatments. The powerful synergy of
the holistic approach of complementary medicine to-
gether with biomedical cancer treatments is central to
the purpose of integrative oncology. The combination
permits dysfunctional physical, mental, emotional, and
spiritual symptoms to be treated and thereby fully ad-
dresses the healing needs of cancer patients in a tai-
lored fashion.
IN THIS SUPPLEMENT
In his article, Dr. Simon Sutcliffe discusses the impor-
tance of combining science and evidence-based medi-
cine with individual and societal values and of
integrating values into a process of holistic care. To
quote Sutcliffe, the goal is ultimately “to achieve a
responsive, efficient, effective, and sustainable sys-
tem to improve health and control cancer (as a pro-
cess, not as an event).” He expands his argument that
complex problems require a more sophisticated ap-
proach than can be achieved through scientific reduc-
tionism, and that the multifaceted perspectives of the
patient must be part of the decision-making process in
designing health policy.
Drs. Jacqueline Bender and Alejandro Jadad ex-
tend the perspective of patients’ values and educa-
tion through individuals socializing over the Internet.
They discuss the potential for empowerment and how
that empowerment may modify the relationships of
patients with their health care providers. Dr. Alastair
Cunningham emphasizes the existential crisis that pa-
tients endure when they receive a diagnosis of cancer
and speaks of the importance of psychological healing
as part of the process of restoring health. And Dr. Mary
Vachon expands on the notion of spirituality and mean-
ing for cancer patients in her article “The Soul’s Wis-
dom: Stories of Living and Dying” (e-manuscript on
the Web).
How is outcome to be evaluated in an integrative
oncology program? Dr. Stephen Sagar discusses vari-
ous health outcome domains and patient satisfaction,
and points to some validated measurement tools. For
a detailed source of measurement tools, readers are
also directed to the new online IN-CAM Outcomes
Database (www.outcomesdatabase.org) organized by
Dr. Marja Verhoef.
Dr. Sagar and Dr. Raimond Wong together provide
an educational article on integrative oncology research
and regulation (e-manuscript on the Web). Further e-
manuscripts recount the experiences of two interna-
tional integrative oncology programs: Dr. Jane Maher,
Chief Medical Officer of MacMillan Cancer Support,
describes the Lynda Jackson Macmillan Centre at
Mount Vernon Hospital in Northwood, United King-
dom, and Dr. Gary Deng describes the Integrative
Medicine Service at Memorial Sloan–Kettering Hos-
pital, headed by Dr. Barrie Cassileth, in New York City,
United States. Both centres have pioneered similar
models in other countries.
Attendees of the University of Toronto Integrating
Wellness into Cancer Care Conference participated in
a workshop titled “How to Put Wellness on the Pre-
scription Pad”, and in another e-manuscript, Dr. Fortin
presents a summary of the discussions that took place.
A group of manuscripts from the Cancer, Comple-
mentary and Alternative Medicine (CCAM) team, a
multidisciplinary group of Canadian scientists, presents
some of their work in evaluating the role of comple-
mentary therapies for cancer care.
Dr. Ann Leis discusses the scope of integrative
oncology and the need for evidence to support the inte-
gration of complementary therapies into cancer care.
She concludes that “a whole-systems framework to
the development of the evidence base for integrative
oncology can guide the development of evidence that
respects the complex nature of many complementary
and integrative practices and their underlying principles
of care delivery.”
In her manuscript “Talking to Cancer Patients
About Complementary Therapies,” Marja Verhoef
concludes that discussing CAM with patients is the
physician’s responsibility and that it will facilitate evi-
dence-based, patient-centred cancer care.
Dr. Lynda Balneaves uses research from the Ca-
nadian health literature to address the issue of patient
decision-making. In her discussion, she says that “de-
cision to use, or not to use, CAM is not a one-time whim-
sical decision; instead, it is a decision that leads cancer
patients to reflect on their unique personal and social
context and to ponder how CAM may fit with their val-
ues, beliefs, and specific health care needs. As the in-
dividual and social contexts of patients change, the
appropriateness of select CAM therapies in their treat-
ment regimen also changes. Decisions about CAM are
not static; rather, they are dynamic entities that require
assessment and follow-up by health professionals
throughout a patient’s illness.”
Why do some patients decline conventional evi-
dence-based therapies and pursue alternative non-
proven options? Dr. Verhoef concludes that “poor
doctor–patient communication, the emotional impact
of the cancer diagnosis, perceived severity of conven-
tional treatment side effects, a high need for decision-SAGAR and LEIS
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making control, and strong beliefs in holistic healing
appear to affect the decision by patients to decline some
or all conventional cancer treatments.” The “tendency
by doctors to dichotomize patient decisions as ratio-
nal or irrational may interfere with the ability of the
doctors to respond with sensitivity and understanding,”
she continues.
Doctor of naturopathic medicine Dugald Seeley,
together with Dr. Doreen Oneschuk, discusses the im-
portant topic of interactions of natural health products
with biomedical cancer treatments.
These subjects require knowledgeable physicians
and a modification of medical school curricula, a task
that is being undertaken by the CAM in UME Project
(www.cam inume.ca/about.html) and the Consortium
of Academic Health Centers for Integrative Medicine
(www.im consortium.org).
What, then, are the current integrative practices of
Canadian health care professionals? Dr. Alison Bra-
zier uses an interpretive–description research design,
with a series of in-depth qualitative interviews, to high-
light two main strategies: acting as an integrative can-
cer guide and collaborating with other health care
professionals.
Mind–body techniques derived from Eastern mys-
ticism have become an important part of some inte-
grative oncology programs. In a research paper that
evaluates an Iyengar yoga program, Ms. Meghan
Duncan finds an overall improvement in the well-be-
ing of cancer patients (e-manuscript on the Web). This
research contributes further to the evidence that some
techniques derived from Eastern spirituality can help
some patients cope with cancer and its treatment.
THE WAY FORWARD
The future of complementary therapies lies in main-
stream medicine, but only if those therapies are based
on scientific understanding and evidence of effec-
tiveness. A willingness to discard therapies that fail
to be proved effective in clinical studies is vital.
Accepted therapies must also be seen to be safe and
cost-effective.
A comprehensive cancer program should integrate
surgery, chemotherapy, radiotherapy, and targeted
molecular therapies with meaningful psycho-spiritual,
psychological, and physical supportive therapies, and
an investigative program of botanicals. New technol-
ogy is facilitating the quality-controlled preparation of
simple and complex mixtures of phytochemicals that
are being investigated as biologic response modifiers.
International collaboration between North American,
European, and Asian universities and interested phar-
maceutical companies is encouraging the development
of multi-targeted therapies using traditional herbs.
During a recent visit by S.M.S. to Fudan University
in Shanghai, China, that institution ratified a collabo-
rative research agreement with the M.D. Anderson
Hospital (the largest international cancer centre) and
signed a new collaborative agreement with the Institut
Gustav Roussy (Europe’s largest cancer centre), un-
der the umbrella of integrative oncology. Video extracts
of the Shanghai conference of the Society for Integra-
tive Oncology can be found on the Current Oncology
Web site. Further information on the Society for Inte-
grative Oncology and its conferences (including ab-
stracts from its recent conference held in Shanghai)
can be found at www.integrativeonc.org.
YOUR PART IN THE DISCUSSION
Readers are invited to evaluate this special supplement
by answering a short survey on the Current Oncology
Web site. The editors appreciate your interest in this
supplement and will similarly appreciate receiving your
comments. We would like to publish those comments
on the Web site; the option of anonymity for specific
comments is available.
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